Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy

Ian C. Marschner*, Ann C. Collier, Robert W. Coombs, Richard T. D'Aquila, Victor DeGruttola, Margaret A. Fischl, Scott M. Hammer, Michael D. Hughes, Victoria A. Johnson, David A. Katzenstein, Douglas D. Richman, Laura M. Smeaton, Stephen A. Spector, Michael S. Saag

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

207 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences